Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical PracticeHideki Iwamoto, Taizo Yamaguchi, Ryoko Kuromatsu et al.|Cancers|2021Cited by 59
Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion ChemotherapyHiroaki Nagamatsu, Michio Sata, Satoshi Itano et al.|The American Journal of Gastroenterology|2004Cited by 55
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findingsSakae Nagaoka, Michio Sata, Satoshi Itano et al.|Liver International|2006Cited by 45
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al.|Cancers|2021Cited by 32
Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infectionShuji Sumie, Michio Sata, Takumi Kawaguchi et al.|Oncology Reports|2007Cited by 27